Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation

Therapeutic Drug Monitoring

Volumn 30, Issue 6, 2008, Pages 643-646

  Brüggemann, Roger J M ^a   Antonius, Tim ^a   Van Heijst, Arno ^a   Hoogerbrugge, Peter M ^a   Burger, David M ^a   Warris, Adilia ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ECMO; Fungal infection; Pharmacokinetics; Therapeutic drug monitoring; Voriconazole

Indexed keywords

ACICLOVIR; CEFTAZIDIME; GALACTOMANNAN; GENTAMICIN; LIVER ENZYME; MERCAPTOPURINE; MEROPENEM; METHOTREXATE; TEICOPLANIN; VORICONAZOLE;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; AREA UNDER THE CURVE; ARTICLE; ASPERGILLUS FUMIGATUS; B CELL LEUKEMIA; CANNULATION; CASE REPORT; CHILD; CONTINUOUS HEMOFILTRATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; EXTRACORPOREAL OXYGENATION; FLUID RETENTION; HEMATOTHORAX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; NEPHROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SPUTUM CULTURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS PNEUMONIA;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD, PRESCHOOL; DRUG MONITORING; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; MALE; PYRIMIDINES; TRIAZOLES;

EID: 57749088942     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181898b0c     Document Type: Article

References (14)

1. van Heijst A, Liem D, van der Staak F, et al. Hemodynamic changes during opening of the bridge in venoarterial extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2001;2:265-270.
2. EMEA. Vfend; Summary of Product Characteristics. Available at: http://www.emea.europa.eu/htms/human/epar/v.htm. Accessed January, 25, 2008.
3. Lequier L. Extracorporeal life support in pediatric and neonatal critical care: a review. J Intensive Care Med. 2004;19:243-258.
4. Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet. 2003;42:403-417.
5. Mehta NM, Halwick DR, Dodson BL, et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 2007;33:1018-1024.
6. Walsh TJ, Driscoll T, Groll AH, et al. Population pharmacokinetic (POP-PK) analysis of voriconazole (VRC): developing a rationale for dosage in pediatric patients. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17, 2007; Chicago, IL. Abstract M620.
7. Purkins L, Wood N, Ghahramani P, et al. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrob Agents Chemother. 2002;46:2546-2553.
8. Robatel C, Rusca M, Padoin C, et al. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient. J Antimicrob Chemother. 2004;54:269-270.
9. Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201-211.
10. Bruggemann RJ, Donnelly JP, Aarnoutse RE, et al. Therapeutic drug monitoring of voriconazole. Ther Drug Monit. 2008;30:403-411.
11. Andes D, Marchillo K, Stamstad T, et al. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Antimicrob Agents Chemother. 2003;47:3165-3169.
12. Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother. 2004;48:2166-2172.
13. von Mach MA, Burhenne J, Weilemann LS. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy. BMC Clin Pharmacol. 2006;6:6.
14. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-360.